Vacinação Página 4

Iniciar Sessão

NEJM - An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

The New England Journal of MedicineThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine...

NEJM - Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models

The New England Journal of MedicineThe third coronavirus outbreak in the past 20 years, the SARS-CoV-2 pandemic has caused unprecedented morbidity, mortality, and economic disruption. Safe, effective, and deployable SARS-CoV-2 vaccines are...

NEJM - Developing Covid-19 Vaccines at Pandemic Speed

The New England Journal of MedicineThe need to rapidly develop a vaccine against SARS-CoV-2 comes at a time of explosion in basic scientific understanding, including in areas such as genomics and structural biology, that is supporting a new era...

WHO - Bacille Calmette-Guérin (BCG) vaccination and COVID-19

World Health OrganizationThere is no evidence that the Bacille Calmette-Guérin vaccine (BCG) protects people against infection with COVID-19 virus. Two clinical trials addressing this question are underway, and WHO will evaluate the evidence when...

1 2 3 4

Categorias

Arquivo de Notícias